saccharin has been researched along with Fatty Liver in 1 studies
Saccharin: Flavoring agent and non-nutritive sweetener.
saccharin : A 1,2-benzisothiazole having a keto-group at the 3-position and two oxo substituents at the 1-position. It is used as an artificial sweetening agent.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aims of this study were to develop an experimental model of ALD, through a high-fat diet, the chronic use of ethanol, and intragastric alcohol binge; and to evaluate the composition of the gut microbiota and its correlation with markers of inflammatory and liver disease progression in this model." | 1.91 | Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters. ( Álvares-da-Silva, MR; Cerski, CTS; Leonhardt, LC; Longo, L; Pereira, MHM; Rampelotto, PH; Thoen, RU, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thoen, RU | 3 |
| Longo, L | 3 |
| Leonhardt, LC | 3 |
| Pereira, MHM | 3 |
| Rampelotto, PH | 3 |
| Cerski, CTS | 3 |
| Álvares-da-Silva, MR | 3 |
1 other study available for saccharin and Fatty Liver
| Article | Year |
|---|---|
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
Topics: Animals; Ethanol; Fatty Liver; Gastrointestinal Microbiome; Lipids; Liver; Liver Diseases, Alcoholic | 2023 |
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
Topics: Animals; Ethanol; Fatty Liver; Gastrointestinal Microbiome; Lipids; Liver; Liver Diseases, Alcoholic | 2023 |
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
Topics: Animals; Ethanol; Fatty Liver; Gastrointestinal Microbiome; Lipids; Liver; Liver Diseases, Alcoholic | 2023 |
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
Topics: Animals; Ethanol; Fatty Liver; Gastrointestinal Microbiome; Lipids; Liver; Liver Diseases, Alcoholic | 2023 |
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
Topics: Animals; Ethanol; Fatty Liver; Gastrointestinal Microbiome; Lipids; Liver; Liver Diseases, Alcoholic | 2023 |
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
Topics: Animals; Ethanol; Fatty Liver; Gastrointestinal Microbiome; Lipids; Liver; Liver Diseases, Alcoholic | 2023 |
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
Topics: Animals; Ethanol; Fatty Liver; Gastrointestinal Microbiome; Lipids; Liver; Liver Diseases, Alcoholic | 2023 |
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
Topics: Animals; Ethanol; Fatty Liver; Gastrointestinal Microbiome; Lipids; Liver; Liver Diseases, Alcoholic | 2023 |
Alcoholic liver disease and intestinal microbiota in an experimental model: Biochemical, inflammatory, and histologic parameters.
Topics: Animals; Ethanol; Fatty Liver; Gastrointestinal Microbiome; Lipids; Liver; Liver Diseases, Alcoholic | 2023 |